AltnerNet:  “We should be very wary about the DEA allowing regulation and marketing of pharmaceutical products containing plant-derived THC.   ‘Marijuana has no scientifically proven medical value.’ So stated the United States Drug Enforcement Administration (DEA) on page six of a July 2010 agency white paper, titled “DEA Position on Marijuana.  Yet only four months after the agency committed its ‘no medical pot’ stance to print, it announced its intent to allow for the regulation and marketing of pharmaceutical products containing plant-derived THC — the primary psychoactive ingredient in cannabis.